Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
14
Jul |
FDA Warns Against Placing A Mesh Through The Vagina To Repair Pelvic Organ ProlapseCategory: Women's Health / Gynecology | Leave a Comment |
The surgical placement of mesh via the vagina to repair pelvic organ prolapse may be riskier for the patient compared to other surgical procedures, the FDA (Food and Drug Administration) has warned doctors. The FDA adds that other options carry less risk than this transvaginal surgical procedure…
|
26
Apr |
French Regulator Confirms Non-toxicity Of PIP Breast Implants, UKCategory: Women's Health / Gynecology | Leave a Comment |
The French medical device regulator, AFSSAPS, has released the findings of comprehensive testing carried out on Poly Implant Prosthese (PIP) silicone breast implants following health concerns raised in 2010…
|
2
Dec |
Outcomes For Robotic-Assisted Hysterectomy Similar To Conventional Laparoscopy, Study FindsCategory: Women's Health / Gynecology | Leave a Comment |
Two methods of performing a minimally invasive hysterectomy — either by a surgeon alone or with assistance of robotic equipment — produced similar, positive outcomes in women with endometrial cancer, according to a study in the journal Obstetrics & Gynecology, Reuters reports…
|
22
Sep |
12-Month Study Reports Efficacy Rates For AMS’ Elevate Apical And Posterior Prolapse Repair SystemCategory: Women's Health / Gynecology | Leave a Comment |
American Medical Systems® (AMS) (Nasdaq: AMMD), a leading provider of world-class devices and therapies for both male and female pelvic health, announced the results of a 12-month single-arm, prospective multi-center study of the Elevate® Apical and Posterior Prolapse Repair System…
|
25
Aug |
Alternative Surgeries For California Women Suffering From FibroidsCategory: Women's Health / Gynecology | Leave a Comment |
The Reproductive Science Center of the San Francisco Bay Area (RSC) is hoping to recruit 150 women suffering from uterine fibroids, benign tumors that can cause extreme pain and infertility. Fibroids are non-cancerous tumors or growths in the wall of the uterus. The cause of uterine fibroid tumors is unknown. Fifty percent of all women develop these tumors during their lifetime…
|
31
Jul |
Thirty Million Women Will Gain From Health Reform Law, Including About 15 Million UninsuredCategory: Women's Health / Gynecology | Leave a Comment |
Approximately thirty million American women will gain from the new health reform law over the next ten years, according to a new report from The Commonwealth Fund, a private foundation based in New York…
|
16
Mar |
Zapping Uterine Fibroids With Heat From High-energy Sound WavesCategory: Women's Health / Gynecology | Leave a Comment |
There’s a new interventional radiology tool showing promise in the treatment of uterine fibroids: magnetic resonance-guided focused ultrasound (MRgFUS), a minimally invasive treatment that uses high-energy ultrasound waves to generate heat at a specific point to destroy uterine fibroid tissue and relieve symptoms…
|
25
Nov |
New Laparoscopy Tools Advance Care For Common Gynecological AilmentsCategory: Women's Health / Gynecology | Leave a Comment |
Laparoscopic surgeons received their first glimpse of Cook Medical’s uterine manipulator/injectors (UMI) last week at the 38th Global Congress of Minimally Invasive Gynecology, sponsored by the American Association of Gynecologic Laparoscopists (AAGL).
|
23
Nov |
Very Common Condition In Women That Often Goes Undiagnosed Now Identifiable By Medical Imaging TechniqueCategory: Women's Health / Gynecology | Leave a Comment |
In women with lower urinary tract symptoms, a medical imaging technique called dynamic MRI allows clinicians to diagnose pelvic organ prolapse - a condition that often goes undiagnosed on static MRI and at physical examination, according to a study published in the December issue of the American Journal of Roentgenology. Pelvic organ prolapse is relatively common and occurs when the pelvic floor muscles become weak or damaged and can no longer support the pelvic organs.
|
2
Oct |
FDA Approves Additional Use For IUD Mirena To Treat Heavy Menstrual Bleeding In IUD UsersCategory: Women's Health / Gynecology | Leave a Comment |
The U.S. Food and Drug Administration approved Mirena (levonorgestrel intrauterine system) to treat heavy menstrual bleeding in women who use intrauterine contraception as their method of pregnancy prevention. This is the first intrauterine device approved by the FDA for this additional indication. Mirena was approved as a contraceptive by the FDA in 2000. It is a small, flexible hormone-releasing device inserted into the uterus to prevent pregnancy.